APA (7th ed.) Citation

Hsieh, Y., Joo, S. K., Koo, B. K., Lin, H., Lee, D. H., Chang, M. S., . . . Kim, W. (2023). Myosteatosis, but not Sarcopenia, Predisposes NAFLD Subjects to Early Steatohepatitis and Fibrosis Progression. Clinical gastroenterology and hepatology, 21(2), 388-397.e10. https://doi.org/10.1016/j.cgh.2022.01.020

Chicago Style (17th ed.) Citation

Hsieh, Yun-Cheng, Sae Kyung Joo, Bo Kyung Koo, Han-Chieh Lin, Dong Hyeon Lee, Mee Soo Chang, Jeong Hwan Park, Young Ho So, and Won Kim. "Myosteatosis, but Not Sarcopenia, Predisposes NAFLD Subjects to Early Steatohepatitis and Fibrosis Progression." Clinical Gastroenterology and Hepatology 21, no. 2 (2023): 388-397.e10. https://doi.org/10.1016/j.cgh.2022.01.020.

MLA (9th ed.) Citation

Hsieh, Yun-Cheng, et al. "Myosteatosis, but Not Sarcopenia, Predisposes NAFLD Subjects to Early Steatohepatitis and Fibrosis Progression." Clinical Gastroenterology and Hepatology, vol. 21, no. 2, 2023, pp. 388-397.e10, https://doi.org/10.1016/j.cgh.2022.01.020.